|

Opdualag Clinical Trials

3 actively recruiting trials across 1 location

Also known as: BMS-986213

Pipeline

Phase 2: 1Phase 1/2: 2

Top Sponsors

  • University Health Network, Toronto1
  • Krystal Biotech, Inc.1
  • Australian & New Zealand Children's Haematology/Oncology Group1

Indications

  • Cancer3
  • Melanoma Stage IV2
  • Cutaneous Melanoma2
  • Childhood Solid Tumor1
  • Childhood Brain Tumor1

Other2 trials

Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma
Phase 2
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Phase 1/2

Los Angeles, California1 trial

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

UCLA Health

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.